U.S. Marine and Shipping Stock News

Wondering whether Babcock & Wilcox Enterprises at US$15.63 is offering value or just headlines? This article breaks down what the current share price might really imply. The stock has seen sharp recent moves, with returns of 10.3% over 7 days, 79.9% over 30 days and 146.1% year to date, while the 1-year return is very large off its prior level. Recent news coverage has focused on Babcock & Wilcox Enterprises as part of broader discussions around capital goods and energy related...

TransMedics Group expanded its National Organ Care System Program, aiming to handle a larger share of U.S. transplant procedures. The company is advancing kidney and lung transplant initiatives, including full control of the ENHANCE clinical trial. TransMedics is preparing simultaneous U.S. and Europe clinical trial launches for its kidney program as part of a broader transplant platform push. TransMedics Group, NasdaqGM:TMDX, is pushing beyond its medical device roots toward a more...

AngloGold Ashanti (NYSE:AU) has released a Technical Report Summary for its Arthur Gold Project in Nevada. The report identifies Arthur as a Tier One gold deposit. New Probable Mineral Reserves have been established for the project. AngloGold Ashanti plans to progress Arthur towards a full feasibility study following this report. For investors following gold producers, AngloGold Ashanti is a large, diversified miner with assets across several regions, and Arthur adds another project in a...

Wondering if California Water Service Group at around US$43.94 is offering fair value right now, or if the price is out of line with what you are actually getting. The stock is up 1.5% over the last 7 days and 2.3% year to date, but it has seen a 5.3% decline over 30 days and a 2.7% decline over the past year, which can change how the market is weighing risk and return. Recent coverage has focused on how regulated utilities like California Water Service Group respond to changing funding...

Earlier in March 2026, Forgent Power Solutions, Inc. filed a follow-on offering of 30,000,000 shares of its Class A common stock and reported second-quarter fiscal 2026 results showing sales of US$296.4 million with net income of US$0.246 million. The company also issued revenue guidance for the second half and full fiscal year 2026 and drew strong media attention for its role supplying electrical distribution equipment for AI data centers, putting both its capital-raising and growth...

Lumen Technologies (NYSE:LUMN) has been named to Fast Company's 2026 list of the World’s Most Innovative Companies in the Enterprise category. This is Lumen’s first appearance on the list and reflects external recognition of its efforts in digital network services. Lumen Technologies enters this recognition period with its shares at $6.97 and a mixed recent track record, including a 6.2% gain over the past week and a 6.4% decline over the past 30 days. Over longer periods, the stock shows a...

If you are wondering whether Floor & Decor Holdings at around US$52.77 is starting to look attractive, the key is understanding what that price really represents in terms of value. The stock has seen a 2.6% decline over the last 7 days, a 22.8% decline over the last 30 days, a 16.2% decline year to date, and a 36.2% decline over the last year, which can change how the market views both its potential and its risks. Recent coverage has focused on how the share price performance has reshaped...

Nutanix (NasdaqGS:NTNX) has been selected as a key ingress and Gateway API provider using Traefik Proxy. This move follows the Kubernetes community’s retirement of the widely used ingress NGINX project. Nutanix leadership has confirmed the decision, aligning the company with other major cloud vendors on Traefik Proxy. The shift affects Kubernetes workloads on Nutanix platforms and clarifies migration paths for existing customers. Nutanix, trading at $38.99, is in focus as the Kubernetes...

Wondering whether TriNet Group's share price reflects its true worth, or if the market is mispricing the stock right now. TriNet Group recently closed at US$36.99, with a 9.3% gain over the last 30 days, but returns of a 1% decline over 7 days and a 52.5% decline over the past year put those moves in a wider context. These price moves come as investors reassess the stock in light of broader company and sector developments, with sentiment shifting over recent months. While the share price...

Permian Basin Royalty Trust (NYSE:PBT) has announced a dividend decrease. The change affects upcoming distributions to unitholders and updates the trust's income profile. Permian Basin Royalty Trust holds royalty interests in oil and gas properties, so its cash distributions are closely tied to production volumes and commodity prices. A dividend adjustment like this can signal that recent cash receipts from underlying properties differ from prior periods. For income focused investors, the...

Wondering if Merck at around US$119 per share still offers value, or if most of the upside is already reflected in the price? This article walks through the key data points that matter for you. Merck’s share price sits near US$119.37, with returns of 4.3% over 7 days, a 3.6% decline over 30 days, 12.1% year to date and 40.4% over the past year. This raises fair questions about both growth potential and how risk is being priced in. Recent news coverage around Merck has focused on its position...

If you are wondering whether Commerce Bancshares at around US$48.54 is starting to look like value, or still has more room to fall or recover, this article will walk you through what the current price might be implying. The stock has gained 2.2% over the last 7 days, although it remains 7.1% lower over the past month and 17.1% lower over the last year. This may have some investors reassessing both its potential and its risks. Recent attention on the broader US banking sector, shifts in...

If you are wondering whether MetLife's current share price reflects its underlying worth, the recent moves in the stock give you plenty to think about. The shares last closed at US$70.39, with a 2.6% gain over the past week, a 6.4% decline over 30 days, and returns of 12.4% decline year to date and 13.6% decline over the last year, set against gains of 36.7% and 34.8% over 3 and 5 years respectively. Recent headlines around MetLife have focused on the business as a large US insurer,...

Cadence Design Systems (NasdaqGS:CDNS) has appointed Dr. Alok Jain as Managing Director for India. The appointment positions India as a key innovation and R&D hub for the company’s semiconductor and design software efforts. Dr. Jain is expected to focus on relationships across government, academia, and industry within India’s growing chip ecosystem. Cadence Design Systems, a major player in electronic design automation and semiconductor IP, is putting more executive weight behind India as a...

Wondering if Moderna at US$53.54 is a bargain or a value trap? This article walks through what the numbers are really saying about the stock. The share price return sits at 2.2% over 7 days, 6.5% over 30 days, 73.5% year to date and 70.1% over the last year, alongside a 64.0% decline over 3 years and a 59.1% decline over 5 years. Recent headlines around Moderna have focused on its position in the pharmaceutical and biotech space and how investors are reassessing companies in this part of the...

Investor activism meets softer quarterly results AutoNation (AN) is facing closer investor scrutiny after a softer Q4, with revenue down 3.9% year on year and earnings missing analyst estimates, even as After-Sales and Customer Financial Services reported record gross profit. See our latest analysis for AutoNation. AutoNation's share price has softened recently, with a 30 day share price return of 1.64% decline and a 90 day share price return of 8.82% decline, even as the 1 year total...

Wondering if Oncolytics Biotech at around US$0.95 is offering value or just extra risk? This article breaks down what that price tag could really mean for you. The stock is roughly flat year to date with a 3.4% decline. It has returned 54.7% over the last year, which can raise questions about how much potential or risk might already be reflected in the price. Recent coverage has focused on Oncolytics Biotech's progress as a clinical stage cancer therapy developer and the implications of its...

Valero Energy (NYSE:VLO) is facing a worker lawsuit that alleges negligence after the recent explosion at its Port Arthur refinery. The suit claims gross negligence related to safety practices and working conditions at one of Valero's largest facilities. This legal action adds fresh scrutiny to the company's operational risk management and potential liability exposure. Valero is one of the largest independent refiners in the US, with operations that supply transportation fuels and other...

If you are wondering whether BioCryst Pharmaceuticals at US$9.40 still offers value, it helps to start by lining up the recent share performance with what the fundamentals suggest the stock might be worth. Over the short term, the share price return sits at 2.6% over 7 days, 24.0% over 30 days and 25.3% year to date, with a 20.5% return over 1 year and 9.8% over 3 years, compared with a 5 year return of a 7.6% decline. These moves are occurring as investors continue to respond to ongoing...

Over the last 7 days, the United States market has remained flat, yet it has risen by 16% over the past year with expectations of earnings growing annually by a similar rate in the coming years. In this context of steady growth, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and potential to outperform these promising market conditions.

In the last week, the United States market has stayed flat, although it is up 16% over the past year with earnings forecasted to grow by 16% annually. In this environment, identifying stocks trading below their estimated intrinsic value can present opportunities for investors seeking potential growth at a reasonable price.

If you are wondering whether Pitney Bowes at around US$10.91 is still offering value or if the easy part of the move is behind it, the starting point is understanding how its current price lines up with different valuation checks. The stock has posted returns of 11.3% over the last 7 days, 5.1% over the past month, 5.6% year to date and 18.6% over the last year, while the 3 year return is very large and the 5 year return sits at 61.5%. Recent headlines have focused on Pitney Bowes in the...

If you are wondering whether Redwire's current share price lines up with its underlying worth, this article will walk you through what the numbers are actually saying. Redwire's share price closed at US$9.16 recently, with a 12.8% return over the last 30 days, a 1.4% return year to date, and a 17.1% decline over the past year, while the 3-year return sits at a very large gain. Recent coverage has focused on Redwire within the Aerospace and Defense space, with attention on how the business is...

In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by 16%, with earnings forecasted to grow at a similar rate annually. In this context of steady growth, stocks with strong insider ownership can be particularly appealing as they often indicate confidence in a company's future prospects and alignment between management and shareholders.